Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Hilda E Garay-Pérez"'
Autor:
Franklin Fuentes, Jesús Junco, Lesvia Calzada, Yovisleydis Lopez, Eulogio Pimentel, Roberto Basulto Baker, Osvaldo Reyes Acosta, Hilda E Garay-Pérez, Gerardo Guillén-Nieto
Publikováno v:
Biotecnología Aplicada, Vol 31, Iss 3, Pp 222-227 (2014)
In this study is described the effect of different doses of the gonadotropin releasing hormone (GnRH) mimetic peptide GnRHm1-TT, administered in three immunization schemes to define the most effective alternative combination for the treatment of pros
Externí odkaz:
https://doaj.org/article/10889b799e2540cba44f6824ac362f01
Autor:
Amalia Hernández-Santana, Elianys Correa-Arguelles, Hilda E Garay-Pérez, Osvaldo Reyes-Acosta, David Diago-Abreu, Ania Cabrales-Rico, Dagmara Pichardo-Díaz, Dioslaida Urquiza-Noa, Pedro Puente-Pérez, Yunier Rodríguez-Álvarez
Publikováno v:
Journal of peptide science : an official publication of the European Peptide SocietyREFERENCES. 27(3)
Interleukin (IL)-15 plays an important role in several inflammatory diseases. We have previously identified an IL-15 antagonist called P8 peptide, which binds specifically to IL-15 receptor alpha subunit. However, the P8 peptide rapidly degraded by p
In vitro and in vivo characterization of an interleukin-15 antagonist peptide by metabolic stability
Autor:
Yunier, Rodríguez-Álvarez, Ania, Cabrales-Rico, Alejandro, Perera-Pintado, Anais, Prats-Capote, Hilda E, Garay-Pérez, Osvaldo, Reyes-Acosta, Erik, Pérez-García, Araceli, Chico-Capote, Alicia, Santos-Savio
Publikováno v:
Journal of peptide science : an official publication of the European Peptide Society. 24(4-5)
Interleukin (IL)-15 is an inflammatory cytokine that constitutes a validated therapeutic target in some immunopathologies, including rheumatoid arthritis (RA). Previously, we identified an IL-15 antagonist peptide named [K6T]P8, with potential therap
Autor:
Araceli Chico-Capote, Ania Cabrales-Rico, Osvaldo Reyes-Acosta, Erik Pérez-García, Anaís Prats-Capote, Alejandro Perera-Pintado, Hilda E Garay-Pérez, Alicia Santos-Savio, Yunier Rodríguez-Álvarez
Publikováno v:
Journal of Peptide Science. 24:e3078
Interleukin (IL)-15 is an inflammatory cytokine that constitutes a validated therapeutic target in some immunopathologies, including rheumatoid arthritis (RA). Previously, we identified an IL-15 antagonist peptide named [K6T]P8, with potential therap